Plasma Total Antioxidant Activity in Comparison with Plasma NO and VEGF Levels in Patients with Metabolic Syndrome
Authors:
- 25 May 2008
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 60 (1) , 87-92
Abstract
Introduction: The aim of our study was to estimate plasma antioxidant activity as well as plasma nitric oxide (NO) and vascular endothelial growth factor levels in patients with metabolic syndrome compared with healthy participants. Material and Methods: Fifty patients (24 women and 26 men, mean age 55.9 ± 11.8 years) with metabolic syndrome were compared with 25 healthy participants (12 women and 13 men, mean age 54.2 ± 12.8 years). Plasma total antioxidant activity and plasma levels of NO and VEGF were determined in all participants. Results: In the patients with metabolic syndrome, plasma total antioxidant activity, nitric oxide, and vascular endothelial growth factor were significantly lower ( P < .001) than that observed in healthy participants (3.2 ± 1.6 vs 6.4 ± 2.1 mM/L), (6.3 ± 2.2 vs 9.8 ± 2.7 μM/L), and 71.0 ± 16.9 vs 137.5 ± 12.6 pg/mL), respectively. Conclusions: Decreased plasma total antioxidant activity, NO, and VEGF levels in patients with metabolic syndrome reflect significant endothelial dysfunction. This suggests that oxidation–reduction balance disorders might play an important role in this processKeywords
This publication has 28 references indexed in Scilit:
- Neutrophil Superoxide Anion Generation During Atorvastatin and Fluvastatin Therapy Used in Coronary Heart Disease Primary PreventionJournal of Cardiovascular Pharmacology, 2006
- Prevention and Treatment of the Metabolic SyndromeAngiology, 2004
- Shouldering the Risk Factor BurdenCirculation, 2002
- Predisposition to Atherosclerosis by InfectionsCirculation, 2002
- Fundamentals of Endothelial Function for the Clinical CardiologistCirculation, 2002
- Vascular Superoxide Production by NAD(P)H OxidaseCirculation Research, 2000
- [2] Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration1999
- VEGF–nitric oxide reciprocal regulationNature Medicine, 1997
- Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.Journal of Clinical Investigation, 1997
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996